Arixa Capital Advisors, a private real estate lender and investment manager, launched a $100 million joint venture with funds managed by Oaktree Capital Management to originate senior secured loans backed by residential and commercial real estate.
Rayonier Advanced Materials (RYAM), a producer of high-purity cellulose specialties and other sustainable materials, obtained $250 million in aggregate principal amount of secured term loan financing from funds managed by Oaktree Capital Management.
Oaktree Capital Management closed its life sciences lending fund and its related vehicles, with total capital commitments in excess of $2.3 billion. The fund, which is Oaktree’s first dedicated life sciences fund, was oversubscribed.
Seres Therapeutics, a microbiome therapeutics company, entered into a new $250 million senior secured debt facility provided by funds managed by Oaktree Capital Management. Seres drew the first tranche of $110 million at closing, with three additional tranches available.
Oaktree Capital Management closed Oaktree European Capital Solutions Fund III, a private debt fund that closed with a total capital commitment of €1.2 billion ($1.33 billion).
Harrow, a U.S. eyecare pharmaceutical company, entered into a $100 million secured credit financing agreement with funds managed by Oaktree Capital Management.
Oaktree Capital Management launched its private credit-focused Oaktree Lending Partners and its related vehicles (OLP). OLP is targeting $10 billion in equity commitments from institutional investors.
scPharmaceuticals entered into a binding term sheet with respect to a $100 million secured debt facility with funds managed by Oaktree Capital Management.
Oxford Biomedica, a gene and cell therapy group, refinanced the $85 million secured 12-month loan facility from funds managed by Oaktree Capital Management.
Itafos entered into credit facilities with a syndicate of lenders led by RBC Capital Markets, pursuant to which the lenders have advanced an $85 million term loan to the company and made available a $35 million letter of credit facility and an $80 million asset-based revolving credit facility.